Authors:
BAUMANN P
NIL R
BERTSCHY G
JECKER A
BRANDLI H
MORAND J
KASAS A
VUAGNIAUX O
RAMSEIER F
Citation: P. Baumann et al., A DOUBLE-BLIND DOUBLE-DUMMY STUDY OF CITALOPRAM COMPARING INFUSION VERSUS ORAL-ADMINISTRATION, Journal of affective disorders, 49(3), 1998, pp. 203-210
Authors:
EAP CB
BERTSCHY G
BAUMANN P
FINKBEINER T
GASTPAR T
GASTPAR M
SCHERBAUM N
Citation: Cb. Eap et al., HIGH INTERINDIVIDUAL VARIABILITY OF METHADONE ENANTIOMER BLOOD-LEVELSTO DOSE RATIOS, Archives of general psychiatry, 55(1), 1998, pp. 89-90
Authors:
BERTSCHY G
BRYOIS C
BONDOLFI G
VELARDI A
BUDRY P
DASCAL D
MARTINET C
BAETTIG D
BAUMANN P
Citation: G. Bertschy et al., THE ASSOCIATION CARBAMAZEPINE-MIANSERIN IN OPIATE WITHDRAWAL - A DOUBLE-BLIND PILOT-STUDY VERSUS CLONIDINE, Pharmacological research, 35(5), 1997, pp. 451-456
Citation: F. Ferreres et al., ANTIDEPRESSANT TREATMENT BEFORE HOSPITALIZATION FOR MAJOR DEPRESSION - OFTEN PRESCRIBED, OFTEN UNDERTITRATED, Pharmacological research, 35(1), 1997, pp. 33-36
Citation: Cb. Eap et al., FLUVOXAMINE AND FLUOXETINE DO NOT INTERACT IN THE SAME WAY WITH THE METABOLISM OF THE ENANTIOMERS OF METHADONE, Journal of clinical psychopharmacology, 17(2), 1997, pp. 113-117
Citation: P. Baumann et G. Bertschy, LONG-TERM TREATMENT OF DEPRESSION - IS THERE A USE FOR DEPOT ANTIDEPRESSANTS, International clinical psychopharmacology, 12(2), 1997, pp. 77-80
Authors:
VANDEL P
BONIN B
BERTSCHY G
BAUMANN P
BOUQUET S
VANDEL S
SECHTER D
BIZOUARD P
Citation: P. Vandel et al., OBSERVATIONS OF THE INTERACTION BETWEEN TRICYCLIC ANTIDEPRESSANTS ANDFLUVOXAMINE IN POOR METABOLIZERS OF DEXTROMETHORPHAN AND MEPHENYTOIN, Therapie, 52(1), 1997, pp. 74-76
Authors:
BONDOLFI G
CHAUTEMS C
ROCHAT B
BERTSCHY G
BAUMANN P
Citation: G. Bondolfi et al., NON RESPONSE TO CITALOPRAM IN DEPRESSIVE PATIENTS - PHARMACOKINETIC AND CLINICAL CONSEQUENCES OF A FLUVOXAMINE AUGMENTATION, Psychopharmacology, 128(4), 1996, pp. 421-425
Citation: G. Bondolfi et al., RISPERIDONE AND REVERSIBLE NEUTROPENIA - A NEGATIVE RECHALLENGE, European neuropsychopharmacology, 6(3), 1996, pp. 257-257
Citation: G. Bertschy et al., FLUOXETINE ADDITION TO METHADONE IN ADDICTS - PHARMACOKINETIC ASPECTS, Therapeutic drug monitoring, 18(5), 1996, pp. 570-572
Authors:
VANDEL S
BERTSCHY G
BAUMANN P
BOUQUET S
BONIN B
FRANCOIS T
SECHTER D
BIZOUARD P
Citation: S. Vandel et al., FLUVOXAMINE AND FLUOXETINE - INTERACTION STUDIES WITH AMITRIPTYLINE, CLOMIPRAMINE AND NEUROLEPTICS IN PHENOTYPED PATIENTS, Pharmacological research, 31(6), 1995, pp. 347-353
Citation: G. Bertschy, METHADONE-MAINTENANCE TREATMENT - AN UPDATE, European archives of psychiatry and clinical neuroscience, 245(2), 1995, pp. 114-124
Citation: G. Bertschy et P. Baumann, VULNERABILITY TO FLUOXETINE-INDUCED INDIFFERENCE SYNDROME AMONG OPIATE ADDICTS - A CASE-REPORT, Biological psychiatry, 38(6), 1995, pp. 404-406
Citation: G. Bertschy et al., PROBABLE METABOLIC INTERACTION BETWEEN METHADONE AND FLUVOXAMINE IN ADDICT PATIENTS, Therapeutic drug monitoring, 16(1), 1994, pp. 42-45
Citation: G. Bertschy et al., RHABDOMYOLYSIS AFTER MODERATE ALCOHOL-ABUSE AND PHYSICAL-TRAINING DURING AMESERGIDE TREATMENT, Therapie, 49(2), 1994, pp. 151-152